#ifrx - Twitter Hashtag

about 4 hours ago

InflaRxが経口C5aR阻害薬izicopanの非臨床データをKidney Week 2026で発表へ、腎疾患領域への展開を加速補体経路を標的とする独InflaRx（IFRX、ナスダック上場、株価は2026年10月2日終値で1.72ドル近辺）は10月2日… https://t.co/UabrcBVkzu #米国株 #IFRX #補体C5aR

0

79

Share_Talk ™

@Share_Talk

about 2 months ago

@Share_Talk Shares Daily, Wednesday 19th August 2026 • Top Risers #OA45 #BANK #NFX #LGLD #MII • Top Fallers #MODE #NOG #ORQP #IFRX #NARF • Top Volume #BZT #FORG #PREM #ROCK #TRP • Most Traded #ANTO #RR #HSBA #AZN #GLEN

Share_Talk ™

@Share_Talk

about 2 months ago

The FTSE 100 reversed early losses to close higher on Wednesday, gaining 15.31 points, or 0.1%, to 10,743.35, as falling bond yields and a surge in precious-metals stocks supported the London market. London’s mid-cap FTSE 250 gained 0.3% to 24,643.52, while the AIM All-Share jumped 0.9% to 801.54. Precious-metals miners were among London’s strongest performers as a weaker dollar helped gold surge to $4,483 an ounce. Oil remained another focus for investors, with Brent crude climbing above $92 a barrel amid continued uncertainty surrounding the Middle East conflict. 🔗 Read the full article here: https://t.co/Lh8xnveaHP

Share_Talk's tweet photo. The FTSE 100 reversed early losses to close higher on Wednesday, gaining 15.31 points, or 0.1%, to 10,743.35, as falling bond yields and a surge in precious-metals stocks supported the London market. London’s mid-cap FTSE 250 gained 0.3% to 24,643.52, while the AIM All-Share jumped 0.9% to 801.54.

Precious-metals miners were among London’s strongest performers as a weaker dollar helped gold surge to $4,483 an ounce. Oil remained another focus for investors, with Brent crude climbing above $92 a barrel amid continued uncertainty surrounding the Middle East conflict. 🔗 Read the full article here: https://t.co/Lh8xnveaHP

0

8

7

2

3K

0

9

6

1

2K

Andromeda 8 Music @Andromeda8Music

7 months ago

@andrewdc208 #AUGM 111p bid #AVG HY Adj EBITDA +10.4% #BGEO FY ptp +20.9% #CAPD,#EARN contracts #FGEN Dec NAV 104.6p #GSK acq #HMSO +ve outlook #HSX FY ptp +7% #IFRX IPO on LSE #MEGP inline, delayed results,not aware of issue #MGNS FY eps +33% #NBB acq Society #TRCS inline, contract #VIC acq

0

10

0

239

jackin @jackin528318

10 months ago

Inflarx $IFRX I'm an individual investor and I'm extremely disappointed with your company. You wanted to make money from both research and development and sales channels. But in the end, because you didn't cooperate with professional large-scale pharmaceutical companies,#IFRX

1

2

0

337

Anun.Trades 🇺🇸

@AnunTrades

11 months ago

UPDATE ‼️ 💥 $IFRX #IFRX — Entry: $1.75 → HOD: $2.05 (+17.1%)

0

1

0

Ethan @Royccillssx1

11 months ago

$IFRX exploding 50% post-close – here’s why it matters. Beyond INF904’s success, its flagship vilobelimab still holds FDA EUA for COVID-19 patients on ventilators/ECMO 🏥, providing steady revenue (Q2 2025: $50k, beating estimates). #IFRX #StockSurge

Royccillssx1's tweet photo. $IFRX exploding 50% post-close – here’s why it matters. Beyond INF904’s success, its flagship vilobelimab still holds FDA EUA for COVID-19 patients on ventilators/ECMO 🏥, providing steady revenue (Q2 2025: $50k, beating estimates). #IFRX #StockSurge https://t.co/tMse8UiVat

1

2

0

1

696

Anun.Trades 🇺🇸

@AnunTrades

11 months ago

UPDATE ‼️ 💥 $IFRX #IFRX — Entry: $1.75 → HOD: $1.95 (+11.4%)

0

3

1

0

I Know First

@i_Know_First

about 1 year ago

Implied Volatility Options Based on Artificial Intelligence: Returns up to 47.68% in 7 Days https://t.co/giNdjvwAyW #lcid #open #onds #gpro #gme #mbot #ifrx #nvda #tsla #up #stocks #stockmarket #stocktrading #investing

i_Know_First's tweet photo. Implied Volatility Options Based on Artificial Intelligence: Returns up to 47.68% in 7 Days
https://t.co/giNdjvwAyW

#lcid #open #onds #gpro #gme #mbot #ifrx #nvda #tsla #up #stocks #stockmarket #stocktrading #investing https://t.co/DHZDfaxafM

0

6

5

0

364

O2

@O248528307

over 1 year ago

$IFRX The next $CLDX? Celldex ran 30x after urticaria data. InflaRx targets the same indication with key readouts in 2025.  Same setup, same potential? Look familiar? #biotech #stocks #IFRX #CLDX #investing

O248528307's tweet photo. $IFRX The next $CLDX? Celldex ran 30x after urticaria data. InflaRx targets the same indication with key readouts in 2025.
 Same setup, same potential?

Look familiar?
#biotech #stocks #IFRX #CLDX #investing https://t.co/Gsi04yV8JP

0

2

0

1

471

@StreetCred2018

@StreetCred2017

over 1 year ago

@OzmosiHealth PG patients, take note: $IFRX’s INF904 Phase 2a kicks off by year-end. Oral therapy targeting C5aR could ease the pain. Summer ‘25 data might spark a breakout! #IFRX #INF904

0

2

0

83

Jon henson

@Bezel4455

over 1 year ago

$IFRX: Big news! 🚀 European Commission approves GOHIBIC® (vilobelimab) for treating SARS-CoV-2-induced ARDS. 🌍 A huge step in combating severe respiratory conditions—watch this biotech closely! 💊🔥 #Biotech #IFRX #COVID19

0

4

0

482

CSIMarket.com @CSIMarket

over 2 years ago

#COVID19 #InflarxNv #IFRX #MajorPharmaceuticalPreparations HeadlineBiopharmaceutical Company, InflaRx Pharmaceuticals, Launches Commitment Program to Improve Access to GOHIBIC for COVID-19 Patients: $IFRX InflaRx Pharmaceuticals Inc., a subsidiary of… https://t.co/Q2vNZXXtFv

CSIMarket's tweet photo. #COVID19 #InflarxNv #IFRX #MajorPharmaceuticalPreparations HeadlineBiopharmaceutical Company, InflaRx Pharmaceuticals, Launches Commitment Program to Improve Access to GOHIBIC for COVID-19 Patients: $IFRX InflaRx Pharmaceuticals Inc., a subsidiary of… https://t.co/Q2vNZXXtFv https://t.co/BzHbavHxlt

0

1

0

189

CSIMarket.com @CSIMarket

over 2 years ago

#IFRX #C5aR #InflarxNv #IFRX #ClinicalStudy Unveiling the Promise: InflaRx's INF904 Sets New Benchmarks as a Best-in-Class C5aR Inhibitor: $IFRX Inflammation is a complex immune response that plays a crucial role in various diseases, including… https://t.co/kNZapAV5gP

CSIMarket's tweet photo. #IFRX #C5aR #InflarxNv #IFRX #ClinicalStudy Unveiling the Promise: InflaRx's INF904 Sets New Benchmarks as a Best-in-Class C5aR Inhibitor: $IFRX Inflammation is a complex immune response that plays a crucial role in various diseases, including… https://t.co/kNZapAV5gP https://t.co/YAeYLmiAgf

0

2

1

0

185

Precise Stock Alerts

@PreciseStocks

over 3 years ago

To Get Real-Time Alerts Join Us Today! https://t.co/k6LggL6BXc $IFRX has been alerted 25 Times ! From "$4.28 (4/5/2023, 4:43:00 AM)" to "$6.58 (4/5/2023, 1:14:00 PM)" with a "53.74%" Gain! #IFRX #stockmarket #daytrading #bullish #bearish #nasdaq #onlinemoney $SPY $QQQ $SPX

0

2

0

161

TraderBambu @TraderBambu

over 3 years ago

$IFRX Nice pump-and-dump #IFRX #smallcap #scalping #DayTrading #Daytrader

0

3

0

215

IKnowFirst Research @IKFResearch

about 4 years ago

Stock Market Forecast: IFRX Increased by 7.81% https://t.co/vVXBwBQDQS The IKF AI algorithm suggested InflaRX N.V. (IFRX) as one of the most promising stocks on July 27, 2022. #IFRX #ai #stockmarketforecast #stockmarket #algorithmicforecast #iknowfirst #beststocks

IKFResearch's tweet photo. Stock Market Forecast: IFRX Increased by 7.81%
https://t.co/vVXBwBQDQS
The IKF AI algorithm suggested InflaRX N.V. (IFRX) as one of the most promising stocks on July 27, 2022.

#IFRX #ai #stockmarketforecast #stockmarket #algorithmicforecast #iknowfirst #beststocks https://t.co/xpgjeA4cFP

0

3

0

I Know First

@i_Know_First

about 4 years ago

Stock Market Forecast: IFRX Increased by 7.81% https://t.co/KGZ922uMDQ The IKF AI algorithm suggested InflaRX N.V. (IFRX) as one of the most promising stocks on July 27, 2022. #IFRX #ai #stockmarketforecast #stockmarket #algorithmicforecast #iknowfirst #beststocks